The Market Reports

Synopsis
The global market for Yellow Fever Vaccines was estimated to be worth US$ 140 million in 2024 and is forecast to a readjusted size of US$ 186 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Yellow fever vaccine is a vaccine that can prevent yellow fever. The vaccination targets are people who enter or pass through the epidemic area.
The global Yellow Fever Vaccines market is primarily driven by the increasing risk of yellow fever outbreaks, particularly in endemic regions such as sub-Saharan Africa and parts of South America. Growing international travel and global mobility have heightened the need for preventive vaccination, especially in travelers visiting high-risk areas. Government-led immunization programs and World Health Organization (WHO) initiatives, such as the Eliminate Yellow Fever Epidemics (EYE) strategy, also contribute to increased vaccine demand. Moreover, rising public health awareness and emergency stockpiling by international health agencies are enhancing market growth, with mass vaccination campaigns being conducted to prevent potential epidemics.
Despite the demand, the Yellow Fever Vaccines market faces several significant challenges. Limited global manufacturing capacity can lead to supply shortages during epidemic surges, causing delays in immunization programs. The vaccine requires cold chain logistics and must be stored at controlled temperatures, which poses distribution challenges in low-resource settings. Additionally, adverse reactions to the live-attenuated vaccine—though rare—can affect public perception and vaccination uptake. Regulatory hurdles and the long timeline for clinical trials and approval of newer formulations or alternatives also slow down market expansion, especially as newer manufacturers attempt to enter the space.
Emerging trends in the Yellow Fever Vaccines market include increased public-private partnerships to scale up vaccine production and improve distribution infrastructure. Technological advancements are pushing toward the development of thermostable formulations to overcome cold chain barriers. There is also rising investment in regional vaccine manufacturing hubs, particularly in Africa, to reduce reliance on global supply chains. Enhanced surveillance systems, digital vaccination records, and integration of yellow fever vaccines into routine immunization schedules are improving coverage rates. Moreover, the expansion of travel-related vaccine requirements and efforts to ensure universal access in endemic regions are expected to drive long-term market growth.
Global Yellow Fever Vaccines key players include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, etc. Global top three manufacturers hold a share about 90%. Middle East and Africa is the largest market, with a share about 70%, followed by South America, and Europe, both have a share about 30 percent. In terms of application, the largest application is Routine Immunization, followed by Travelers.
This report aims to provide a comprehensive presentation of the global market for Yellow Fever Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Yellow Fever Vaccines by region & country, by Distribution Channel, and by Application.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Yellow Fever Vaccines cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Yellow Fever Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Yellow Fever Vaccines.
Market Segmentation
By Company
Sanofi Pasteur
Bio-Manguinhos
FSUE Chumakov
Institut Pasteur de Dakar
Segment by Distribution Channel
Institonal Contributions
Private Purchase
Others
Segment by Application
Routine Immunization
Travelers
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Yellow Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Yellow Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Yellow Fever Vaccines in country level. It provides sigmate data by Distribution Channel, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index